best-ecg-ekg-course

Probably the best ECG book in the world.

Join thousands of students and professionals.

We offer a complete and comprehensive online course in clinical ECG interpretation. Our course covers all topics, from basic cardiac electrophysiology to advanced ECG interpretation and clinical management. It is suitable for anyone interested in ECG interpretation, e.g physicians, assistant physicians, nurses, paramedics, EMTs, biomedical analysts, students and researchers. All recommendations presented here are in line with guidelines issued by the American Heart Association (AHA), the American College of Cardiology (ACC), the European Society for Cardiology (ESC) and the International Society for Holter and Non-Invasive Electrocardiology (ISHNE). We currently offer a time-limited introductory price. The membership is not a subscription; it is a one-time cost that gives you permanent access to the current course and all future updates.

Register

Permanent membership – Professionals

$ 19

Permanent membership – Students

$ 15

Billing details

Your order

Product
Quantity
Total
Cart Subtotal$ 0
Order Total$ 0
  • Pay directly with your credit card


100% No-risk money back guarantee

You are fully protected by our 100% No-Risk-Double-Guarantee.  If you don’t like our course over the next 14 days, then we will happily refund 100% of your money. No questions asked.

We take security seriously

We use a range of physical, technical, and administrative measures to safeguard your information. In particular, all connections to and from our website are encrypted using Secure Socket Layer (SSL) technology. We never store any sensitive information on our servers. Payments are managed safely by PayPal and Stripe.

Frequently Asked Questions (FAQ)

No. This is not a subscription. You only pay once and get permanent access to the course, including future updates.

The purpose of ECGwaves.com is to fill an important gap in ECG education. Because most clinicians and students experience ECG interpretation as complicated, they often turn to books that present it as something simple. Such books tend to oversimplify the concepts, leaving out important clinical aspects, necessary discussions on differential diagnoses and clinical management. The purpose of ECGwaves.com is to provide an e-book that covers every aspect of clinical ECG interpretation, from pathophysiology to evidence based clinical management.

The ECG book is very detailed, yet easy to understand. Every chapter and topic is built up gradually, so that students and beginners are able to comprehend with ease. Details are provided successively, so that even the most experienced clinician (including cardiologists and electrophysiologists) will find it useful. Our users include the whole spectrum of health care personnel, including students, physicians, PAs, nurses, paramedics, EMTs, BMAs, researchers etc.

The ECG book is very detailed, yet easy to understand. Every chapter and topic is built up gradually, so that students and beginners are able to comprehend with ease. Details are provided successively, so that even the most experienced clinician (including cardiologists and electrophysiologists) will find it useful. Our users include the whole spectrum of health care personnel, including students, physicians, PAs, nurses, paramedics, EMTs, BMAs, researchers etc.

ECGWaves.com includes (1) a complete and comprehensive e-book on clinical ECG interpretation (consisting roughly of 400 A4-pages), (2) a comprehensive section on coronary artery disease and (3) a section on exercise stress testing. All chapters and sections are combined together, which you can view in Course overview. The membership gives you access to the entire content.

Feel free to contact us to issue a refund if the course did not meet your expectations.

No. ECGwaves.com includes ECG test, video lectures, book chapters and much more. All of these components are updated every week, with additions to chapters and videos etc. You do have, however, access to the entire site permanently when you register as a member.

Numerous academic institutions and hospitals use ECGwaves.com. Discounts are available. If you represent an academic institution or hospital, please contact us for further information. User accounts are usually created with 1 to 2 business days.

The author

Dr Araz Rawshani, MD, PhD

This book and course is created by Dr Araz Rawshani (MD, PhD) from the University of Gothenburg, Sweden. Dr Rawshani is a cardiovascular researcher with interest in acute and cardiovascular medicine, as well as diabetology. His research encompasses both clinical studies and basic science. Dr Rawshani has published papers in The New England Journal of Medicine, The Lancet, JAMA (Internal Medicine), The British Medical Journal etc. Dr Rawshani serves as reviewer for more than 30 peer-reviewed journals and teaches evidence-based cardiology and ECG interpretation at all levels. Dr Rawshani is currently the co-director of the Swedish Cardiopulmonary Resuscitation Registry.

Dr Araz Rawshani, MD, PhD
Institute of Medicine Department of Clinical and Molecular Medicine
University of Gothenburg, Sweden

  • Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. Rawshani A, Rawshani A, Franzén S, Sattar N, Eliasson B, Svensson AM, Zethelius B, Miftaraj M, McGuire DK, Rosengren A, Gudbjörnsdottir S. The New England Journal of Medicine. 2018 Aug 16;379(7):633-644.
  • Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Rawshani A, Sattar N, Franzén S, Svensson A-M, Eliasson B, Rawshani A, Gudbjörnsdottir S. The Lancet.
  • Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes. Rawshani ARawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbjörnsdottir S. The New England Journal of Medicine. 2017 Apr 13;376(15):1407-1418.
  • Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.
  • Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbjörnsdottir S. Circulation. 2017 Apr 18;135(16):1522-1531.
  • Type 1 diabetes mellitus. Katsarou A, Gudbjörnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark Å. Nature Reviews. 2017 Mar 30;3:17016.
  • Association Between Socioeconomic Status and Mortality, Cardiovascular Disease, and Cancer in Patients With Type 2 Diabetes. Rawshani A, Svensson AM, Zethelius B, Eliasson B, Rosengren A, Gudbjörnsdottir S. JAMA Intern Med. 2016 Aug 1;176(8):1146-54. doi: 10.1001/jamainternmed.2016.2940.
  • Association Between Use of Lipid-Lowering Therapy and Cardiovascular Diseases and Death in Individuals With Type 1 Diabetes. Hero C, Rawshani A, Svensson AM, Franzén S, Eliasson B, Eeg-Olofsson K, Gudbjörnsdottir S. Diabetes Care. 2016 Jun;39(6):996-1003.
  • Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study. Rosengren A, Vestberg D, Svensson AM, Kosiborod M, Clements M, Rawshani A, Pivodic A, Gudbjörnsdottir S, Lind M. The Lancet Diabetes Endocrinol. 2015 Nov;3(11):876-85.
  • Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register. Steinarsson AO, Rawshani A, Gudbjörnsdottir S, Franzén S, Svensson AM, Sattar N. Diabetologia. 2018 Jan 9.
  • BMI and Mortality in Patients With New-Onset Type 2 Diabetes: A Comparison With Age- and Sex-Matched Control Subjects From the General Population. Edqvist J, Rawshani A, Adiels M, Björck L, Lind M, Svensson AM, Gudbjörnsdottir S, Sattar N, Rosengren A. Diabetes Care. 2018 Jan 3.
  • Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study. Steineck I, Cederholm J, Eliasson B, Rawshani A, Eeg-Olofsson K, Svensson AM, Zethelius B, Avdic T, Landin-Olsson M, Jendle J, Gudbjörnsdóttir S; Swedish National Diabetes Register. British Medical Journal. 2015 Jun 22;350:h3234.
  • Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes. Rawshani A, Svensson AM, Rosengren A, Eliasson B, Gudbjörnsdottir S. Diabetes Care. 2015 Aug;38(8):1518-27.
  • The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods. Rawshani A, Landin-Olsson M, Svensson AM, Nyström L, Arnqvist HJ, Bolinder J, Gudbjörnsdottir S. Diabetologia. 2014 Jul;57(7):1375-81. doi: 10.1007/s00125-014-3225-9. Epub 2014 Apr 9. 
  • Metabolic characteristics of individuals at a high risk of type 2 diabetes – a comparative cross-sectional study. Henninger J, Rawshani A, Hammarstedt A, Eliasson B. BMC Endocr Disord. 2017 Jul 14;17(1):40.
  • Cephalic phase of insulin secretion in response to a meal is unrelated to family history of type 2 diabetes. Eliasson B, Rawshani A, Axelsen M, Hammarstedt A, Smith U. PLoS One. 2017 Mar 13;12(3):e0173654.
  • Recent trends in life expectancy for people with type 1 diabetes in Sweden. Petrie D, Lung TW, Rawshani A, Palmer AJ, Svensson AM, Eliasson B, Clarke P. Diabetologia. 2016 Jun;59(6):1167-76. doi: 10.1007/s00125-016-3914-7. Epub 2016 Apr 5. 
  • Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population–A prospective cohort study. Henninger J, Hammarstedt A, Rawshani A, Eliasson B. BMC Endocr Disord. 2015 Sep 25;15:51.
  • Impact of ethnicity on progress of glycaemic control in 131,935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register. Rawshani A, Svensson AM, Rosengren A, Zethelius B, Eliasson B, Gudbjörnsdottir S. BMJ Open. 2015 Jun 5;5(6):e007599.